EDESA BIOTECH, INC. Operating Lease, Weighted Average Discount Rate, Percent
EDESA BIOTECH, INC. (EDSA) had Operating Lease, Weighted Average Discount Rate, Percent of 9.20% as of 2025-09-30, per its 10-K filed 2025-12-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2025-12-12
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
- 2025-03-31: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-09-30 | 9.20% 10-K · filed 2025-12-12 |
| 2025-06-30 | 9.20% 10-Q · filed 2025-08-08 |
| 2025-03-31 | 9.20% 10-Q · filed 2025-05-14 |
| 2024-12-31 | 9.20% 10-Q · filed 2025-02-14 |
| 2024-09-30 | 9.20% 10-K · filed 2025-12-12 |
| 2024-06-30 | 9.20% 10-Q · filed 2024-08-09 |
| 2024-03-31 | 9.20% 10-Q · filed 2024-05-10 |
| 2023-12-31 | 9.20% 10-Q · filed 2024-02-09 |
| 2023-09-30 | 9.20% 10-K · filed 2024-12-13 |
| 2023-06-30 | 9.20% 10-Q · filed 2023-08-09 |
| 2023-03-31 | 9.20% 10-Q · filed 2023-05-11 |
| 2022-12-31 | 9.20% 10-Q · filed 2023-02-10 |
| 2022-09-30 | 6.50% 10-K · filed 2023-12-15 |
| 2022-06-30 | 6.50% 10-Q · filed 2022-08-12 |
| 2022-03-31 | 6.50% 10-Q · filed 2022-05-13 |
| 2021-12-31 | 6.50% 10-Q · filed 2022-02-14 |
| 2021-09-30 | 6.50% 10-K · filed 2022-12-16 |
| 2021-06-30 | 6.50% 10-Q · filed 2021-08-13 |
| 2021-03-31 | 6.50% 10-Q · filed 2021-05-14 |
| 2020-12-31 | 6.50% 10-Q · filed 2021-02-16 |
| 2020-09-30 | 6.50% 10-K · filed 2021-12-28 |
| 2020-06-30 | 6.50% 10-Q · filed 2020-08-12 |
| 2020-03-31 | 6.50% 10-Q · filed 2020-05-15 |
| 2019-12-31 | 6.50% 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |